Myrrhe, Kamille und Kaffeekohle in der Therapie von ­Patienten mit Colitis ulcerosa

• Literatur

• 1 Biedermann L, Mwinyi J, Scharl M et al. Bilberry ingestion improves disease activity in mild to moderate ulcerative colitis – An open pilot study. J Crohn‘s Colitis 2013; 7: 271-279
• 2 Cramer H, Schaefer M, Schoels M et al. A randomized controlled trial of yoga for ulcerative colitis. Gastroenterology 2016; 146(5): Suppl. 1
• 3 Elsenbruch S, Langhorst J, Popkirowa K et al. ­Effects of mind-body therapy on quality of life and neuroendocrine and cellular immune functions in patients with ulcerative colitis. Psychother Psychosom 2005; 74: 277-287
• 4 Hanai H, Iida T, Takeuchi K et al. Curcumin maintenance therapy for ulcerative colitis: randomized, multicenter, double-blind, placebo-controlled trial. Clin Gastroenterol Hepatol 2006; 4: 1502-1506
• 5 Lang A, Salomon N, Wu JC et al. Curcumin in combination with mesalamine induces remission in patients with mild-to-moderate ulcerative colitis in a randomized controlled trial. Clin Gastroenterol Hepatol 2015; 13: 1444-1449
• 6 Jedel S, Hoffman A, Merriman P et al. A Randomized controlled trial of mindfulness-based stress reduction to prevent flare-up in patients with inactive ulcerative colitis. Digestion 2014; 89: 142-155
• 7 Langhorst J, Anthonisen IB, Steder-Neukamm U et al. Amount of systemic steroid medication is a strong predictor for the use of complementary and alternative medicine in patients with inflammatory bowel disease: results from a German national survey. Inflamm Bowel Dis 2005; 11: 287-295
• 8 Langhorst J, Varnhagen I, Schneider SB et al. Randomised clinical trial: a herbal preparation of myrrh, chamomile and coffee charcoal compared with mesalazine in maintaining remission in ulcerative colitis – a double-blind, double-dummy study. Aliment Pharmacol Ther 2013; 38: 490-500
• 9 Langhorst J, Anthonisen IB, Steder-Neukamm U et al. Patterns of complementary and alternative medicine (CAM) use in patients with inflammatory bowel disease: Perceived stress is a potential indicator for CAM use. Complement Ther Med 2007; 15: 30-37
• 10 Langhorst J, Frede A, Knott M et al. Distinct ­kinetics in the frequency of peripheral CD4+ T cells in patients with ulcerative colitis experiencing a flare during treatment with mesalazine or with a herbal preparation of myrrh, chamomile, and coffee charcoal. PLoS One 2014; 9: e104257
• 11 Sandborn WJ, Targan SR, Byers VS et al. Andrographis paniculata extract [HMPL-004] for active ulcerative colitis. Am J Gastroenterol 2013; 108: 90-98
• 12 Tang T, Targan SR, Li ZS et al. Randomized clinical trial: herbal extract HMPL-004 in active ulcerative colitis – a double-blind comparison with sustained release mesalazine. Aliment Pharmacol Ther 2011; 33: 194-202
• 13 Vissiennon C, Hammoud D, Goos KH et al. Synergy research: Investigating the combined action of chamomile, myrrh and coffee charcoal on chemokine release of activated human macrophages. Z Phytother 2016; 37 (Suppl. 01) S50
• 14 Vissiennon C, Hammoud D, Jente R et al. Chamomile flower, myrrh and coffee charcoal, components of a traditional herbal medicinal product, diminish pro-inflammatory activation in human macrophages. Z Phytother 2016; 37 (Suppl. 01) S50-S51